Literature DB >> 14167093

SERUM ENZYME STUDIES IN MUSCLE DISEASE. II. SERUM CREATINE KINASE ACTIVITY IN MUSCULAR DYSTROPHY AND IN OTHER MYOPATHIC AND NEUROPATHIC DISORDERS.

J M PEARCE, R J PENNINGTON, J N WALTON.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; CHILD; CREATINE KINASE; ENZYME TESTS; INFANT; MULTIPLE SCLEROSIS; MUSCULAR ATROPHY; MUSCULAR DISEASES; MUSCULAR DYSTROPHY; MYOSITIS; POLYNEURITIS; SPINAL CORD COMPRESSION; SPONDYLITIS, ANKYLOSING; SYRINGOMYELIA

Mesh：

Substances：

Year:  1964        PMID： 14167093      PMCID： PMC495703          DOI： 10.1136/jnnp.27.2.96

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  13 in total

1.  Sources of error in the biochemical diagnosis of muscular dystrophy.

Authors:  W A THOMSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-08       Impact factor: 10.154

2.  Serum creatine-phosphokinase in thyroid disease.

Authors:  F A GRAIG; G ROSS
Journal:  Metabolism       Date:  1963-01       Impact factor: 8.694

3.  Creatinephosphokinase levels in hypothyroidism.

Authors:  P D GRIFFITHS
Journal:  Lancet       Date:  1963-04-20       Impact factor: 79.321

4.  [Study of arteriovenous differences during muscle diseases. 1. Oxygen, glucose & lactic acid. 2. Blood aldolase].

Authors:  J C DREYFUS; G SCHAPIRA; J DEMOS
Journal:  Clin Chim Acta       Date:  1958-11       Impact factor: 3.786

5.  Serum enzyme activity in muscular dystrophy.

Authors:  W H THOMSON; P LEYBURN; J N WALTON
Journal:  Br Med J       Date:  1960-10-29

6.  Serum aldolase in muscle disease.

Authors:  R A THOMPSON; P J VIGNOS
Journal:  AMA Arch Intern Med       Date:  1959-04

7.  Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase.

Authors:  C M PEARSON
Journal:  N Engl J Med       Date:  1957-06-06       Impact factor: 91.245

8.  On the classification, natural history and treatment of the myopathies.

Authors:  J N WALTON; F J NATTRASS
Journal:  Brain       Date:  1954       Impact factor: 13.501

9.  Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons.

Authors:  C M PEARSON; S R CHOWDHURY; W M FOWLER; M H JONES; W H GRIFFITH
Journal:  Pediatrics       Date:  1961-12       Impact factor: 7.124
View more
  12 in total

1.  [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. I. SERUM ENZYMES IN PROGRESSIVE MUSCULAR DYSTROPHY (TYPE I, II, IIIA)].

Authors:  H W ROTTHAUWE; S KOWALEWSKI
Journal:  Klin Wochenschr       Date:  1965-02-01

2.  Serum enzymes in the diagnosis of neuromuscular disorders.

Authors:  T L Munsat
Journal:  Calif Med       Date:  1971-09

3.  Creatine phosphokinase activity in human polymorphonuclear leukocytes.

Authors:  S Traniello; M G D'Aloya; E Grazi
Journal:  Experientia       Date:  1975-03-15

4.  Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.

Authors:  B A Britt; L Endrenyi; P L Peters; F H Kwong; L Kadijevic
Journal:  Can Anaesth Soc J       Date:  1976-05

5.  Androgen receptors in muscle fibers induce rapid loss of force but not mass: implications for spinal bulbar muscular atrophy.

Authors:  Kentaro Oki; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan
Journal:  Muscle Nerve       Date:  2013-04-30       Impact factor: 3.217

6.  Study of creatine phosphokinase, lactic dehydrogenase and transaminases in neuromuscular diseases.

Authors:  R S Singh; S P Agrawal; S K Dikshit
Journal:  Indian J Pediatr       Date:  1973-02       Impact factor: 1.967

Review 7.  Metabolic myopathy.

Authors:  P K Thomas
Journal:  Postgrad Med J       Date:  1967-02       Impact factor: 2.401

8.  Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice.

Authors:  Melissa P Wu; Emanuela Gussoni
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

9.  Immunoassay of muscle-specific creatine kinase with a monoclonal antibody and application to myogenesis and muscular dystrophy.

Authors:  G E Morris; L P Head
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

10.  Development of a high-throughput method for real-time assessment of cellular metabolism in intact long skeletal muscle fibre bundles.

Authors:  Rui Li; Frederik J Steyn; Michael B Stout; Kevin Lee; Tanya R Cully; Juan C Calderón; Shyuan T Ngo
Journal:  J Physiol       Date:  2016-11-03       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.